title: Characterization of adapt33, a stress-inducible riboregulator.
abstract: We have identified adapt33 as a multiple stress-responsive gene that is induced under conditions of a cytoprotective "adaptive response." adapt33 RNA does not contain any appreciable open reading frame nor produce a protein product and is therefore classified as a stress-inducible riboregulator. Although a number of oxidant stress-modulated, protein-encoding genes have been reported and characterized, very few stress-inducible riboregulator RNAs are known. Here we extend previous studies toward understanding the underlying regulation of expression and function of this rare mammalian riboregulator. mRNA stability and transcription studies determined that adapt33 induction by hydrogen peroxide is at the mRNA stability level, and that adapt33 has a very short half-life. Surprisingly, adapt33 mRNA also exhibits altered electrophoretic migration in response to both hydrogen peroxide and cis-platinum treatment. Although no transcriptional modulation in response to hydrogen peroxide was observed, fusion promoter constructs revealed that adapt33 has an unusually strong promoter that is active in both hamster and human cells. Analysis of expression following the stimulation of apoptosis with hydrogen peroxide and staurosporine revealed a strong correlation with apoptosis, suggesting a possible novel, noncoding RNA component of the apoptotic mechanism. We conclude that adapt33 is a stress-inducible, apoptosis-associated RNA with unique structural and gene promoter characteristics.
authors.affiliation: Center for Immunology and Microbial Disease, The Albany Medical College, Albany, NY 12208, USA.
authors.forename: Yanhong
authors.initials: Y
authors.lastname: Wang
authors.forename: Kelvin J A
authors.initials: KJ
authors.lastname: Davies
authors.forename: J Andres
authors.initials: JA
authors.lastname: Melendez
authors.forename: Dana R
authors.initials: DR
authors.lastname: Crawford
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D016466:CHO Cells; D015500:Chloramphenicol O-Acetyltransferase / Q000378:metabolism; D002945:Cisplatin / Q000494:pharmacology; D006224:Cricetinae; D017931:DNA Primers / Q000235:genetics; D018076:DNA, Complementary / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D016877:Oxidants / Q000494:pharmacology; D018384:Oxidative Stress / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism*; D019311:Staurosporine / Q000494:pharmacology; D014158:Transcription, Genetic
chemical_list: D000970:Antineoplastic Agents; D017931:DNA Primers; D018076:DNA, Complementary; D004791:Enzyme Inhibitors; D016877:Oxidants; D012333:RNA, Messenger; D006861:Hydrogen Peroxide; D015500:Chloramphenicol O-Acetyltransferase; D019311:Staurosporine; D002945:Cisplatin